Cancer Immunotherapy Consortium Appoints New Leadership
Wednesday, November 9, 2011 - 13:00
in Health & Medicine
Leading international association of cancer immunotherapy developers, the Cancer Immunotherapy Consortium, appoints James P. Allison, Ph.D., and Axel Hoos, M.D., Ph.D., as co-directors.